Niagen Bioscience (NAGE) Non Operating Income (2010 - 2020)
Niagen Bioscience (NAGE) reported Non Operating Income of -$12000.0 for Q1 2020, down 134.29% year-over-year from $35000.0 in Q2 2019, and up 98.77% quarter-over-quarter from -$972000.0 in Q4 2019.
Niagen Bioscience (NAGE) Non Operating Income (2010 - 2020) Analysis & Trends
Niagen Bioscience (NAGE) has 11 years of Non Operating Income data on file, last reported at -$12000.0 in Q1 2020.
- Non Operating Income for Q1 2020 came in at -$12000.0, down 134.29% year-over-year; the trailing twelve-month figure through Jun 2020 was -$984000.0 (down 351.02% YoY), and the FY2019 annual result was -$847000.0, down 1229.33% from the prior year.
- Non Operating Income advanced to -$12000.0 in Q1 2020 per NAGE's latest filing, from -$972000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $241000.0 in Q4 2018 and troughed at -$972000.0 in Q4 2019.
- A 5-year average of -$105381.2 and a median of -$28000.0 in 2017 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2017 and 2018: Non Operating Income slumped 1891.15% in 2017, then surged 647.32% in 2018.
- A 5-year view of Non Operating Income shows it stood at -$18360.0 in 2016, then slumped by 139.83% to -$44033.0 in 2017, then surged by 647.32% to $241000.0 in 2018, then slumped by 503.32% to -$972000.0 in 2019, then surged by 98.77% to -$12000.0 in 2020.
- Business Quant data shows NAGE's Non Operating Income at -$12000.0 in Q1 2020, -$972000.0 in Q4 2019, and $125000.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 9.35 Mn |
| 10 | Niagen Bioscience | 280.11 Mn | 213.56 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -12,000.00 |
| Dec 31, 2019 | -972,000.00 |
| Jun 30, 2019 | 125,000.00 |
| Mar 31, 2019 | 35,000.00 |
| Dec 31, 2018 | 241,000.00 |
| Sep 30, 2018 | -9,000.00 |
| Mar 31, 2018 | -44,000.00 |
| Dec 30, 2017 | -44,033.00 |
| Sep 30, 2017 | -45,000.00 |
| Apr 1, 2017 | -28,000.00 |
| Dec 31, 2016 | -18,360.00 |
| Oct 1, 2016 | -2,260.00 |
| Jul 2, 2016 | -448,416.00 |
| Apr 2, 2016 | -177,350.00 |
| Jan 2, 2016 | -181,299.00 |
| Oct 3, 2015 | -180,846.00 |
| Jul 4, 2015 | -131,132.00 |
| Apr 4, 2015 | -119,431.00 |
| Jan 3, 2015 | -123,652.00 |
| Sep 27, 2014 | -12,219.00 |